Soluble human M-CSF receptor and uses thereof

Details for Australian Patent Application No. 2006342119 (hide)

Owner Novartis AG Xoma Technology Ltd

Inventors Kavanaugh, Michael; Kunich, John; Liu, Cheng; Deuter-Reinhard, Maja

Agent FB Rice

Pub. Number AU-A-2006342119

PCT Pub. Number WO2007/120252

Priority 60/753,218 22.12.05 US

Filing date 21 December 2006

Wipo publication date 25 October 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/120252 Priority application(s): WO2007/120252

2 October 2008 Amendment Made

  The nature of the amendment is: Amend the priority details to read 60/786,131 27 Mar 2006 US and 60/753,218 22 Dec 2005 US 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342137-Glucagon receptor antagonists, preparation and therapeutic uses

2006342115-Nanoporous substrates for analytical methods